LIFECORE BIOMEDICAL, INC. quarterly report, Q2 FY2000

Business Context and Reporting Period

This Form 10-Q covers the fiscal quarter and six months ended April 30, 2000, for Landec Corporation (Note: The input metadata referenced "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as Landec Corporation). Landec operates in two primary segments: Food Products Technology (via its subsidiary Apio, acquired in December 1999) and Agricultural Seed Technology (via Intellicoat). The company designs and sells temperature-activated polymer products for food, agriculture, and industrial applications.

Key Financial Metrics

Metric Three Months Ended Apr 30, 2000 Six Months Ended Apr 30, 2000
Total Revenues $60.8 million $94.6 million
Gross Profit $12.4 million (20.4% margin) $16.6 million (17.6% margin)
Operating Profit $3.2 million $0.6 million
Net Income $2.8 million $0.1 million
Cash and Equivalents $6.5 million (as of Apr 30, 2000) $6.5 million (as of Apr 30, 2000)
Total Debt $28.1 million (incl. current maturities) $28.1 million (incl. current maturities)
Accumulated Deficit ($45.4 million) ($45.4 million)

Material Changes vs. Prior Period

  • Revenue Surge: Revenues increased 218% for the quarter and 287% for the six-month period compared to the prior year. This is primarily driven by the inclusion of Apio, Inc. (acquired Nov 1999), which contributed $40.5 million in quarterly revenue.
  • Margin Compression: Gross profit margins declined from 42% (Q2 1999) to 20% (Q2 2000). Management attributes this to Apio's lower-margin product mix and higher winter crop sourcing costs.
  • Expense Growth: Selling, general, and administrative (SG&A) expenses rose 156% quarter-over-quarter, largely due to Apio integration costs and increased marketing for Intellicoat.
  • Debt Increase: Interest expense jumped from $63,000 to $709,000 for the quarter due to debt assumed and incurred for the Apio acquisition.

Outlook, Risks, and Management Commentary

  • Seasonality: Results are heavily influenced by seasonality. Intellicoat revenues are concentrated in the spring planting season (Q2), while Apio is sensitive to weather and fresh produce pricing.
  • Profitability Warning: Landec has incurred net losses in every fiscal year since inception. Management states there is no assurance it will reach or sustain profitability for a full fiscal year.
  • Debt Covenants: The company carries significant debt ($28.1 million) with restrictive covenants (EBITDA, leverage ratios). Failure to comply could trigger an event of default. Apio's ability to pay dividends to Landec is restricted until debt is reduced.
  • Accounting Changes: Adoption of SAB 101 in fiscal 2001 is expected to result in a non-cash charge of approximately $1 million related to deferred license fees.
  • Liquidity: Management believes existing cash, lines of credit, and new facilities established in June 2000 are sufficient for operations for the next 12 months.

Investor Verification Checklist

  • Apio Integration: Verify if the anticipated operating efficiencies from the Apio acquisition are being realized, given the initial margin compression.
  • Debt Service Capacity: Assess the company's ability to meet strict financial covenants and service $28.1 million in debt amidst seasonal revenue fluctuations.
  • Customer Concentration: Note that the top five customers accounted for 39% of revenues in the first six months; verify stability of these relationships.
  • Future Accounting Impact: Monitor the impact of the upcoming SAB 101 adoption on future revenue recognition and net income.
  • Weather and Supply Chain: Evaluate exposure to adverse weather conditions affecting crop yields and single-source supplier risks for raw materials.